Advanced Biomed Inc.

ADVB Nasdaq SEC CIK 1941029
Follow Advanced Biomed Weekly email: filings, results

Financials

Reported figures only · latest: Q1 2027 USD · US GAAP
Net income −$989.1K −155.6% vs same quarter last year
EPS, diluted −$0.60 −66.7% vs same quarter last year
Operating cash flow −$171.5K +71.9% vs same quarter last year
Operating income −$973.9K −561.8% vs same quarter last year
Net income by quarter
−$907.9K
−$1.4M
−$701.6K
−$386.9K
$6.9M
−$488.9K
$695K
−$989.1K
Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 Q4 26 Q1 27

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income4 fiscal years
−$5M−$2.5M$0$2.5M$5M$7.5MFY23FY24FY25FY26
Show the numbers
YearNet income
FY26$6.7M
FY25−$3.3M
FY24−$2.8M
FY23-